(Q35757881)

10 August 2017

1 reference

title

Gemcitabine-related radiation recall preferentially involves internal tissue and organs (English)

1 reference

10 August 2017

Philip A Friedlander

1

1 reference

10 August 2017

Roopa Bansal

2

1 reference

10 August 2017

Lawrence Schwartz

3

1 reference

10 August 2017

Raquel Wagman

4

1 reference

10 August 2017

Jerome Posner

5

1 reference

10 August 2017

Nancy Kemeny

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

100

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

1793-1799

1 reference

The "recall effect" in radiotherapy: is subeffective, reparable damage involved?

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Gemcitabine-induced radiation recall

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.20229

1 reference

7 January 2021

Radiation myositis: the possible role of gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Radiation recall reaction following gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Characterizing the phenomenon of radiation recall dermatitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Potentiation of x-ray effects by actinomycin D

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

RADIATION AND 5-FLUOROURACIL: A CONTROLLED CLINICAL STUDY

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Radiation recall dermatitis from high-dose interferon alfa-2b.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Radiation recall--another call with tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Stem cell depletion: an explanation of the late effects of cytotoxins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Radiation reaction recall following simvastatin therapy: a new observation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20229

7 January 2021

Identifiers

DOI

10.1002/CNCR.20229

1 reference

10 August 2017

1 reference